Skip to main content
Journal Guides6 min readUpdated Jun 18, 2026

Is Nature Immunology Indexed in PubMed? Yes, With Active MEDLINE Indexing

Nature Immunology is indexed in PubMed and currently indexed for MEDLINE, with searchable coverage beginning from volume 1, issue 1 in July 2000.

By Associate Professor, Clinical Medicine & Public Health•
Author contextAssociate Professor, Clinical Medicine & Public Health. Experience with NEJM, JAMA, BMJ.View profile

Next step

Choose the next useful decision step first.

Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.

Open Journal Fit ChecklistAnthropic Privacy Partner. Zero-retention manuscript processing.Run Free Readiness Scan
Journal context

Nature Immunology at a glance

Key metrics to place the journal before deciding whether it fits your manuscript and career goals.

Full journal profile
Impact factor26.5Clarivate JCR
Acceptance rate~5-8%Overall selectivity
Time to decision5 dayFirst decision

What makes this journal worth targeting

  • IF 26.5 puts Nature Immunology in a visible tier, citations from papers here carry real weight.
  • Scope specificity matters more than impact factor for most manuscript decisions.
  • Acceptance rate of ~5-8% means fit determines most outcomes.

When to look elsewhere

  • When your paper sits at the edge of the journal's stated scope, borderline fit rarely improves after submission.
  • If timeline matters: Nature Immunology takes ~5 day. A faster-turnaround journal may suit a grant or job deadline better.
  • If open access is required by your funder, verify the journal's OA agreements before submitting.

Quick answer: yes.

Nature Immunology is indexed in PubMed, currently indexed for MEDLINE, and searchable from volume 1, issue 1 in July 2000. That matters because immunology papers often need to travel across tumor biology, infection, inflammation, and translational medicine.

PubMed is one of the main ways those adjacent audiences actually find the work after publication.

Direct answer

If you publish in Nature Immunology, the paper is discoverable in PubMed and the journal remains actively indexed for MEDLINE.

NLM field
What the record shows
Why it matters
publication start year
2000
the title has continuous coverage under the current name
PubMed coverage
v1n1, July 2000-
searchable coverage starts from the first issue
MEDLINE coverage
v1n1, July 2000-
the journal sits inside the curated NLM journal index
current indexing status
Currently indexed for MEDLINE
this is active indexing, not residual archive presence
current subset
Index Medicus
the title sits inside the standard biomedical indexing flow
NLM subject cues
Immune System; Immunity; Immunotherapy
the record itself reflects translational adjacency

That is the practical answer. The journal is visible in PubMed, active in MEDLINE, and searchable continuously from launch.

Why this matters for Nature Immunology

The best Nature Immunology papers do not stay inside one specialist lane. They often need to reach:

  • immunologists in neighboring subfields
  • infection and inflammation researchers
  • cancer and tumor-immunology teams
  • clinician-scientists watching translational signals
  • drug-development and biomarker teams evaluating mechanism-to-disease relevance

Those readers often find papers through PubMed searches built around disease, pathway, cell type, or mechanism. Indexing matters because it lets the paper travel through that broader biomedical search workflow.

For this journal, that cross-field travel is not optional. A paper can be immunologically elegant and still underperform if it never becomes legible to adjacent cancer, infection, or translational readers.

What the indexing record tells you in practice

Practical question
What the record tells you
will published papers surface in standard biomedical search?
yes
is the journal actively indexed for MEDLINE?
yes
does searchable coverage start from the first issue?
yes
does indexing prove the paper is deep or important enough for Nature Immunology?
no
does indexing tell you whether the story belongs in a disease-facing journal instead?
no

That last distinction matters because the discoverability answer is easy. The flagship-fit answer is hard.

PubMed versus MEDLINE for Nature Immunology

  • PubMed means the article is visible in the main biomedical search interface used across immunology, oncology, infection, and inflammation research.
  • MEDLINE means the journal remains part of the curated NLM journal index.
  • Index Medicus indicates that the title sits inside the standard biomedical indexing structure.

That matters because Nature Immunology is basic enough to matter to mechanism-focused readers and translational enough to matter to disease-facing readers. PubMed helps the paper reach both.

How this compares with nearby journals

Journal pattern
What the indexing record usually supports
What it does not solve
Nature Immunology
broad immunology plus translational biomedical discoverability
whether the mechanism is deep enough or broad enough
Immunity
strong immunology visibility with Cell Press readership
whether the paper has the same field-defining reach
disease-focused journals
strong audience visibility inside one disease lane
broader immunology signaling
narrower specialty immunology venues
discoverability for one subfield
flagship cross-subfield breadth

This is the useful submission takeaway. Indexing is not the limiting factor for Nature Immunology. Mechanistic depth, breadth of consequence, and generality are the limiting factors.

How to verify the indexing record yourself

If you want to check this directly, the process is short:

  1. open the NLM Catalog record
  1. confirm the PubMed and MEDLINE coverage lines
  1. confirm Current Indexing Status
  1. confirm Current Subset
  1. run a direct journal search in PubMed
  1. compare the latest results with the official journal site

That manual check is useful here because it shows the discoverability answer is clean: the title is searchable from launch and remains actively indexed for MEDLINE.

What we see in PubMed-Indexing Questions for Nature Immunology

For PubMed-indexing questions for Nature Immunology, three patterns recur.

The translational-visibility worry. Authors sometimes assume a mechanistic immunology paper may be harder to find outside the exact subfield. For this journal, the indexing record is usually not the problem. The real challenge is whether the mechanism has enough field-wide consequence.

The indexing-equals-prestige shortcut. We also see authors treat active MEDLINE indexing as proof the journal choice is correct. It is not. A paper can be visible and still be a weak Nature Immunology fit if the evidence is too narrow, too descriptive, or too disease-specific.

The wrong destination comparison. Another frequent mistake is comparing Nature Immunology only with other immunology titles. The real fork is often between Nature Immunology, Immunity, and a disease-facing flagship. Indexing does not settle that fork. Editorial scope does.

What indexing does and does not tell you

This page answers the discoverability question. It does not answer whether the manuscript is significant enough or mechanistically deep enough for Nature Immunology.

Indexing tells you:

  • the published paper will be visible in standard biomedical search
  • the title is actively indexed for MEDLINE
  • searchable coverage begins from the first issue

Indexing does not tell you:

  • whether the mechanism is mature enough
  • whether the paper has enough breadth for the journal
  • whether the story should actually go to a disease-facing venue instead

That is why the better next reads are:

If the fit question is what you actually need answered, a Nature Immunology submission readiness check gives you a manuscript-specific signal before you submit.

What the NLM record means in practice for authors

The useful part of the Nature Immunology record is not just that the title appears in PubMed. It is that the discoverability story is clean from launch and pointed toward the kinds of adjacent readers this journal actually needs.

The title starts in 2000, and the searchable PubMed and MEDLINE coverage starts there as well. That gives authors a simple answer to the database question: if the paper is published here, it will sit in the normal biomedical search flow used by both core immunologists and disease-facing readers.

The subject cues in the NLM record also matter. The emphasis on immune system, immunity, and immunotherapy fits how the journal behaves in practice. The strongest papers here often cross from mechanism into tumor immunology, infection, inflammation, or intervention logic. That cross-field legibility is part of why discoverability matters.

But the record still does not answer the editorial question. Authors often ask whether Nature Immunology is “in PubMed” when the real concern is whether the mechanism is broad enough, causal enough, or important enough for the journal. The NLM record cannot solve that.

Submit If / Think Twice If

Use this indexing answer as enough reassurance if:

  • your main concern is whether a published paper will be visible across immunology-adjacent search behavior
  • you want confirmation that the title remains actively indexed for MEDLINE
  • you need a clean citation showing searchable coverage from launch

Think twice if:

  • you are using PubMed inclusion as a shortcut for flagship fit
  • the manuscript may be too narrow, too descriptive, or too disease-specific for Nature Immunology
  • what you actually need is a mechanistic-depth judgment rather than a database-status answer

Readiness check

Run the scan while the topic is in front of you.

See score, top issues, and journal-fit signals before you submit.

Get free manuscript previewAnthropic Privacy Partner. Zero-retention manuscript processing.See example reports

Practical verdict

Yes, Nature Immunology is indexed in PubMed and currently indexed for MEDLINE, with searchable coverage from volume 1, issue 1 in July 2000.

If your question is whether a published paper will be easy for biomedical readers to find, the answer is yes. If your real question is whether the manuscript truly deserves a Nature Immunology audience rather than Immunity or a disease-facing flagship, that is the harder fit judgment. A Nature Immunology submission readiness check is the best next step if you want that call before submission.

Frequently asked questions

Yes. Nature Immunology is indexed in PubMed and currently indexed for MEDLINE according to the NLM Catalog.

The NLM record shows PubMed and MEDLINE coverage from volume 1, issue 1 in July 2000.

Because immunology papers often need to reach cancer, infection, inflammation, and translational readers who search the literature through PubMed rather than by browsing one journal.

Open the NLM Catalog record, check the PubMed and MEDLINE coverage lines plus current indexing status, then run a direct PubMed journal search for recent Nature Immunology articles.

References

Sources

  1. 1. Nature Immunology NLM Catalog record, NLM.
  2. 2. NLM Catalog help: current indexing status, NLM.
  3. 3. Nature Immunology journal page, Springer Nature.
  4. 4. Nature Immunology author instructions, Springer Nature.
  5. 5. Nature Immunology in PubMed, PubMed.

Before you upload

Choose the next useful decision step first.

Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.

Use the scan once the manuscript and target journal are concrete enough to evaluate.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Open Journal Fit ChecklistRun Free Readiness Scan
Internal navigation

Where to go next

Start here

Same journal, next question

Supporting reads

Conversion step

Back to all articles